A Novel <scp>DNA</scp> Repair‐Gene Model to Predict Responses to Immunotherapy and Prognosis in Patients With <scp>EGFR</scp>‐Mutant Non‐Small Cell Lung Cancer
This study demonstrated a diversity of DDR genes in EGFRm NSCLC and developed a predictive model using these genes. This model could assist in identifying potential candidates for immunotherapy and in assessing personalized treatment and prognosis of patients with EGFRm NSCLC.
Authors
- Xue‐Wu Wei (ORCID: https://orcid.org/0000-0001-6865-8923)
- Chang Lu (ORCID: https://orcid.org/0000-0001-6504-6083)
- Qing Zhou (ORCID: https://orcid.org/0000-0002-0478-176X)
- Zhihong Chen (ORCID: https://orcid.org/0000-0002-9749-2501)
- Fen Wang (ORCID: https://orcid.org/0000-0002-4876-710X)
- Jia‐Yi Deng
- Mingyi Yang (ORCID: https://orcid.org/0000-0003-4347-6239)
- Xiaorong Yang (ORCID: https://orcid.org/0009-0004-1275-304X)
Institutions
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1759-7714.70025
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Ministry of Education, India
- National Science and Technology Major Project